Investing Profile

Asish Xavier

InvestorVC
J&J Innovation - JJDC, Vice President, Venture Investments at Johnson & Johnson
jnjinnovation.com/team/asish-...South San Francisco, California
Photo of Asish Xavier, Vice President at Johnson & Johnson Innovation
Your Intro Paths to Asish Xavier

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Asish is a member of
The Wharton School Network
622 CONNECTIONS
University of Pennsylvania - The Wharton School Network
262 CONNECTIONS
University of Pennsylvania - The Wharton School Network
262 CONNECTIONS
The Johns Hopkins University Network
136 CONNECTIONS
The Johns Hopkins University Network
136 CONNECTIONS

Find Asish Xavier on

cb
Current Investing Position
Johnson & Johnson Innovation Vice President
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
22

Asish Xavier is on these Sector & Stage Rankings

Asish Xavier's Investments On Record (9)

CompanyStageDateRound SizeTotal Raised
SonoThera
Series BJun 2026$130M
Series ADec 2022$61M
$190M
Co-investors: Lori Hu (Vertex Ventures HC), Rajul Jain (Vida Ventures, LLC), Brian Halak (Medical Excellence Capital, LLC), Steven Gillis (ARCH Venture Partners), Tom Willis (Illuminate Ventures), Lu Wang (Foothill Ventures (formerly Tsingyuan Ventures))
PhaseBio Pharmaceuticals
Series CMar 2015$40M
Series BJun 2012$23M
Series BJan 2010$25M
Series UnknownOct 2007$7M
$130M
Co-investors: Justin Klein (Vensana Capital), Robert Ingram (Hatteras Venture Partners), James Barrett
Aduro BioTech
Series CJun 2014$56M
$56M
ViaCyte
Series CJul 2013$11M
Series CJul 2007$25M
Series UnknownMay 2006$20M
$140M
Co-investors: Adam Koppel (Bain Capital Ventures), Heath Lukatch (Novo Holdings)
Protagonist Therapeutics
Series BJun 2013$14M
$54M
Co-investors: Julie Grant (Canaan Partners)
Aquinox Pharmaceuticals
Series CApr 2013$18M
Series BJun 2010$25M
Series AJun 2007$15M
$58M
Gyre Therapeutics
Post Ipo EquityApr 2013$5M
Post Ipo EquitySep 2012$13M
Post Ipo EquityDec 2008$40M
$88M
Co-investors: Nassim Usman (Ribozyme Pharmaceuticals), Ralph (Chris) Christoffersen (Lightstone Ventures)
Nevro
Series CMar 2013$48M
Series BJul 2011$58M
$130M
Co-investors: Peter Bisgaard (Pivotal bioVenture Partners), Paul Klingenstein (Aberdare Ventures)

Asish Xavier's Experience

Member Board Of Directors Verana Health2021 - Present
J&J Innovation - JJDC, Vice President, Venture Investments Johnson & Johnson2007 - Present
Board Observer Message PharmaceuticalsPresent
Member Board of Directors Sound Ave. BistroPresent
Member Board of Directors XWPharmaPresent
Member Board of Directors Cue HealthPresent
Board Member Arialys TherapeuticsPresent
Investor Arkuda TherapeuticsPresent
Board Member Rondo TherapeuticsPresent
Board Observer Capstan TherapeuticsPresent
Board Member Bright Peak TherapeuticsPresent
Investor Link Cell TherapiesPresent
Investor EpiBiologicsPresent
Member Board Of Directors Paige2021 - 2025
Member Board of Directors SonoThera2022 - 2024
Board Observer Pipeline Therapeutics2023 - 2024
Member Board of Directors XWPharma 凯瑞康宁2019 - 2023
Member Board of Directors ESCAPE Bio2015 - 2022
Member Board of Directors ViaCyte2007 - 2022
Member Board of Directors Cue Health Inc.2020 - 2021
Board Observer Datavant2020 - 2021
Investor Legend Biotech2020 - 2020
Member Board Of Directors Fusion Pharmaceuticals2017 - 2020
Member Board of Directors Adicet Bio, Inc2019 - 2019
Member Board of Directors PhaseBio Pharmaceuticals, Inc.2009 - 2017
Board Observer Aduro Biotech, Inc.2014 - 2015
Member Board of Directors BlackThorn Therapeutics2015 - 2015
Member Board of Directors Catalyst Biosciences2007 - 2015
Member Board of Directors Accelerator Life Science Partners2014 - 2014
Member Board of Directors Celladon Corporation2007 - 2014
Board Observer Nevro2011 - 2014
Member Board of Directors Genocea Biosciences2010 - 2014
Member Board of Directors Aquinox Pharmaceuticals, Inc.2006 - 2014
Member Board of Directors Aldeyra Therapeutics2005 - 2014
Member Board of Directors Protagonist Therapeutics2013 - 2013
Board Observer Five Prime Therapeutics, Inc.2006 - 2013
Member Board of Directors Navitor Pharmaceuticals2009 - 2012
Principal, Venture Investments Johnson & Johnson2006 - 2007
Senior Associate, Venture Investments Johnson & Johnson2004 - 2006
Manager, Business Development BioRexis Pharmaceuticals Corporation2003 - 2004
Group Leader, R&D Message Pharmaceuticals1999 - 2001

Asish Xavier's Education

University of Pennsylvania - The Wharton School MBA
Indian Institute of Technology, Kanpur B.Tech. Chemical Engineering
University of Pennsylvania - The Wharton School MBA Finance & Entrepreneurship
The Johns Hopkins University Postdoctoral Fellow Chemistry & Biophysics
University of Houston Ph.D. Chemical Engineering
The Wharton School MBA Finance & Entrepreneurship
The Johns Hopkins University Postdoctoral Fellow
University of Houston Ph.D.
Indian Institute of Technology, Kanpur B.Tech.

Investors who invest with Asish Xavier

Sign in with Google →

Scouts & Angels Affiliated With Asish Xavier

Sign in with Google →